Anixa Biosciences Inc — Director's Dealing 2017

Sep 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-09-06

Reporting Person: MONAHAN JOHN J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-06	Employee Stock Option	$3.13	D	6000	Disposed	2026-08-23	Common Stock (6000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	6000	Acquired	2026-08-23	Common Stock (6000)	Direct
2017-09-06	Employee Stock Option	$5.3	D	12000	Disposed	2027-01-03	Common Stock (12000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	12000	Acquired	2027-01-03	Common Stock (12000)	Direct

Footnotes

F1: These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options.

F2: The option was originally granted on August 23, 2016 and vested 50% on September 30, 2016 and 50% on December 31, 2016.

F3: The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017.